The essence of healthcare has not changed, but the "delivery method" is being rewritten.

In the healthcare industry, the process of "diagnosis-examination-treatment" has never changed, but a transformation regarding the "delivery method" is taking place. On April 28th, RIMAG GROUP (02522) officially announced at the Strategic Upgrade and Smart Imaging + 2.0 launch event that the company will transition from a "medical imaging service provider" to the "world's largest smart imaging + ecological leader". It is believed that behind this strategic upgrade is a value reconstruction based on the underlying logic of "scene + data + AI". The expansion of boundaries from "imaging" to "imaging +" , the technological evolution from "AI 1.0 era single disease recognition" to "AI 3.0 era universal artificial intelligence (AGI) driven by pedestal models", and the shift from "domestic cultivation" to "global replication" in the industry. With 117 entity centers in hand, RIMAG GROUP will transform its closed-loop advantage of "scene-data-AI" into a killer application known as the "Brain CT Super Intelligence Body", and will collaborate with Tencent + universities + top hospitals to build a full-stack AI ecosystem. In doing so, it has actually completed the transition to an industry enabling role. Standing at the crest of the national strategy of "artificial intelligence + healthcare", RIMAG GROUP is rewriting the logic of healthcare service delivery, and its valuation anchor will switch from traditional medical service institutions to a more imaginative "leader in new healthcare infrastructure". Transition from imaging services to intelligent new digital infrastructure: Dual support of technological path and asset foundation As RIMAG GROUP significantly increases investment in its artificial intelligence subsidiary, Yinghemedical, and actively expands into the "imaging+" business, even listing data resources on the Beijing-Shanghai Data Exchange, it has become clear that the underlying framework of its strategic upgrade is in place. These actions are not isolated, but rather a systemic layout transitioning from imaging services to intelligent new digital infrastructure, underlying the construction of a full-chain closed-loop ecosystem of "examination-diagnosis-management-data", with the three core elements of "scene + data + AI" nested together to drive a positive flywheel continuously. In terms of scene density, a network of irreplicable value is being created. By the end of 2025, RIMAG GROUP had established 117 medical imaging centers in 20 provinces, autonomous regions, and municipalities across the country, covering all levels from cities to villages, and offline stores of online internet hospitals. This high-density scene network not only allows medical services to reach a wider range of terminals, but also creates a network effect that single-track players find difficult to achieve, providing ample soil for data sedimentation and AI transformation. In the data dimension, industry-level barriers are becoming the core driving force. Medical imaging data, with its high-dimensional and highly structured features, has always been the scarcest raw material for medical AI training. Through the continuous operation of a network of hundreds of centers, RIMAG GROUP has accumulated the largest medical imaging database in the country, which includes data attributes from all equipment models and body parts, providing high-quality "fuel" for the precise iteration of AI models. On the AI dimension, the technological positioning is moving from an auxiliary tool to a cognitive-level production facility. RIMAG GROUP has defined three eras of medical imaging AI evolution: era 1.0 of single disease recognition, era 2.0 of data-driven multi-disease coverage, and era 3.0 of AGI driven by pedestal models. Currently, the company's technology process is fully entering the construction and implementation of the 3.0 paradigm. The Brain CT Super Intelligence Body released this time is a killer landing product created based on the 3.0 paradigm - covering 90% of brain lesions, with a diagnostic accuracy of nearly 90%. The time it takes to produce a report has been compressed from the traditional 15 minutes to 1 minute. It has already been commercialized and can sustainably and rapidly iterate new products. In terms of research and development mechanisms, a collaborative paradigm of "building databases - building pedestal models - building downstream tasks" has been established, and joint research with Beijing Tiantan Hospital affiliated with Capital Medical University has led to the release of systematic research results in brain medical imaging AI at the 2025 China International Service Trade Fair, marking the company's completion of the scale verification of the combination of medicine and technology in the high-end clinical AI field. It can be seen from the above that the positive flywheel logic formed by the three elements of "scene + data + AI" is clear: more scenes lead to higher quality data sedimentation, more data accelerates the iteration of AI models and products, and stronger AI capabilities in turn improve the quality of service and user stickiness in scenes, driving a new round of scene expansion. This self-perpetuating structure is the fundamental difference between RIMAG GROUP and ordinary imaging center operators, and is the core support for its transition from a service provider to a leader in intelligent new digital infrastructure. Three-dimensional expansion and platform empowerment: Clear growth path of ecosystem entities If the closed-loop ecosystem of "scene + data + AI" is the "structural moat" of RIMAG GROUP at the strategic design level, then the continuous expansion in the dimensions of territory, services, and delivery forms paint a clear growth path for its platform ecosystem entities. This is not linear growth on a single track, but the three-dimensional enhancement of width, depth, and height of the track. In terms of expanding territory, RIMAG GROUP's global footprint is becoming increasingly solid and strategically focused. Its approach to international expansion is not indiscriminate market casting, but rather the replication of mature domestic business models in new geographies. Through a strategic partnership agreement with leading equipment manufacturer Shanghai United Imaging Healthcare to jointly enter overseas markets, the company has established an "equipment + service" penetration model to accurately target the overseas medical market. With the macro backdrop of the government encouraging the internationalization of medical services, this highly replicable model has opened up an imaginative second growth curve for the company. In the deepening of services dimension, the company has completed a strategic transition from single "imaging" to comprehensive "imaging +". With medical imaging as the core, RIMAG GROUP has extended its service tentacles into the depth of comprehensive diagnosis, aiming to elevate its role in the clinical pathway from an "auxiliary tool" to a "core dependency". This fusion of cross-modal data not only expands the boundaries of the business, but also simultaneously enhances the training dimension of AI models and the precision of clinical correlations. At the same time, the "Digital DoctorBuddy" solution jointly created with Tencent is based on the production paradigm of an "AI super factory", packaging this fusion capability into a scalable new paradigm of intelligent imaging services, realizing the standardized output and batch intelligent production of AI models, and building a new generation imaging AI creation engine. In terms of delivery mode, a revolution from fixed centers to "ubiquitous" centers is taking place, which is the most disruptive variable. Mobile examination vehicles are extending diagnostic capabilities proactively to patients, a flexible network like that of Didi is achieving dynamic scheduling of equipment and doctors, and the intervention in health management scenes is shifting examination behaviors from "passive responses" to "active interventions". These three-dimensional expansions together construct a clear strategic growth ladder. Even more critical is that the value boundary of RIMAG GROUP lies in its ability to empower how many medical institutions complete the transformation to a digital era. At the level of capacity output, the company packages its years of accumulated operational systems, information platforms, and AI tools into "plug-and-play" products, allowing grassroots hospitals to enhance diagnostic standards through "turnkey" projects without having to build from scratch. At the level of government cooperation, through actively participating in the construction of regional medical data platforms and completing data services within the regional data trusted space to generate income, the company's strategic role has been elevated from a simple "commercial service entity" to a "participant in public medical data infrastructure". This dual-tracked empowerment strategy allows for a positive resonance between commercial value and social value: the deeper involvement in the construction of public medical systems, the stronger the data assets and brand endorsement; and the stronger the assets and endorsement, the faster the expansion of the commercial ecosystem. Aligned with national strategy and benefiting from policy support for the realization of the value logic of "new infrastructure" under the strategic direction of the country The strategic layout of RIMAG GROUP is highly aligned with the direction of national policies. This alignment is proactive at the strategic design level. Under the national framework of the "artificial intelligence + healthcare" action plan, the core goal is to use AI technology to improve the efficiency and fairness of medical services, with a focus on filling the "capability gap" at the grassroots level of healthcare. RIMAG GROUP's AI products - especially the "Brain CT Super Intelligence Body" - are the most direct commercial carriers of this policy goal. Through AI empowerment, grassroots imaging doctors are able to achieve diagnostic standards close to or even surpassing those of top-tier hospitals, truly achieving the "downward flow of high-quality medical resources". Despite the implementation of the tiered diagnosis and treatment system for many years, the insufficient supply of diagnostic capabilities at the grassroots level has always been the largest systemic obstacle. Through a combination of telemedicine, mobile examinations, flexible services like those of Didi, and the output capabilities, RIMAG GROUP is systematically bridging this gap. This is not only a huge market blue ocean, but also a compulsory demand-driven from a policy perspective. At the same time, against the backdrop of the elementization of medical data and the macro trend of digital healthcare going global, the initiatives of RIMAG GROUP, such as listing data resources on exchanges, participating in data service pilots in the Beijing Data First Zone, and projects in Malawi, accurately hit the core tracks encouraged by national strategies. For companies, if their strategy can achieve sustained resonance with national will, it often means lower policy resistance, more abundant resource support, and a longer dividend period. From this perspective, RIMAG GROUP's positioning in "new infrastructure" is the core logic of its strategic positioning. In conclusion, from a single imaging center to a vast network of 117 centers across the country; from manual image reading to the AGI era of the "Brain CT Super Intelligence Body" producing reports in one minute; from comprehensive domestic coverage to global replication; from individual services to empowering regional medical platforms - every dimension of transition is transforming "new infrastructure" from vision to tangible assets, from narrative to verifiable business reality. The core signal that RIMAG GROUP is conveying to the market is very clear: "We are building a set of underlying capabilities that others find difficult to replicate." This ability is rapidly unleashing growth momentum in the dimensions of scene density, data depth, and AI accuracy. The "delivery method" of healthcare services is being rewritten, and RIMAG GROUP is leading the way in this paradigm shift.